SIRT3 controls cancer metabolic reprogramming by regulating ROS and HIF
- PMID: 21397853
- PMCID: PMC3087169
- DOI: 10.1016/j.ccr.2011.03.001
SIRT3 controls cancer metabolic reprogramming by regulating ROS and HIF
Abstract
In this issue of Cancer Cell, Finley and coworkers report that the genetic loss of the deacetylase SIRT3 leads to metabolic reprogramming toward glycolysis. This shift is mediated by an increase in cellular reactive oxygen species (ROS) generation that amplifies HIF-α stabilization and HIF-dependent gene expression, thereby driving the tumor phenotype.
Copyright © 2011 Elsevier Inc. All rights reserved.
Figures
Comment on
-
SIRT3 opposes reprogramming of cancer cell metabolism through HIF1α destabilization.Cancer Cell. 2011 Mar 8;19(3):416-28. doi: 10.1016/j.ccr.2011.02.014. Cancer Cell. 2011. PMID: 21397863 Free PMC article.
References
-
- Jacobs KM, Pennington JD, Bisht KS, ykin-Burns N, Kim HS, Mishra M, Sun L, Nguyen P, Ahn BH, Leclerc J, Deng CX, Spitz DR, Gius D. SIRT3 interacts with the daf-16 homolog FOXO3a in the mitochondria, as well as increases FOXO3a dependent gene expression. Int J Biol Sci. 2008;4:291–299. - PMC - PubMed
-
- Kim HS, Patel K, Muldoon-Jacobs K, Bisht KS, ykin-Burns N, Pennington JD, van der MR, Nguyen P, Savage J, Owens KM, Vassilopoulos A, Ozden O, Park SH, Singh KK, Abdulkadir SA, Spitz DR, Deng CX, Gius D. SIRT3 is a mitochondria-localized tumor suppressor required for maintenance of mitochondrial integrity and metabolism during stress. Cancer Cell. 2010;17:41–52. - PMC - PubMed
-
- Schumacker PT. A tumor suppressor SIRTainty. Cancer Cell. 2010;17:5–6. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
